Pharmacometric analysis to assess the risk–benefit profile of nintedanib
Exposure-safety analyses are often a great complement to exposure-response analyses in order to drive key MIDD decisions such as therapeutic dose selection. In this example,
Exposure-safety analyses are often a great complement to exposure-response analyses in order to drive key MIDD decisions such as therapeutic dose selection. In this example,
We are happy to have Linda Hafdell onboard as a contract manager. Linda’s previous work experience mainly consists of public procurement within the fields of
Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions..